[TLX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -68.73%
YoY- -102.51%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/01/17 CAGR
Revenue 136,049 4,686 3,606 1,667 195 49 0 -
PBT -27,919 -61,993 -35,157 -25,690 -10,524 -4,806 -1,594 62.22%
Tax 5,269 -13,997 -8,571 -8,192 1,884 -471 -38 -
NP -33,188 -47,996 -26,586 -17,497 -8,640 -4,806 -1,556 67.71%
Tax Rate - - - - - - - -
Total Cost 169,237 52,682 30,192 19,165 8,835 4,854 1,556 120.86%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/01/17 CAGR
NP Margin -24.39 -1,024.24 -737.27 -1,049.33 -4,430.77 -9,850.62 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/01/17 CAGR
EPS -0.10 -0.17 -0.10 -0.07 -0.04 -0.02 -0.01 47.56%
EPS Diluted -0.10 -0.17 -0.10 -0.07 -0.04 -0.02 -0.01 47.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.